Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
CC transcript
Inv. presentation
Quarterly results
Director departure
Emergent BioSolutions Inc. (EBS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
10/02/2023 8-K Quarterly results
08/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Emergent’s Statement Regarding the Passing of a Director of the Board"
08/08/2023 8-K Quarterly results
Docs: "LUTIONS REPORTS FINANCIAL RESULTS FOR SECOND QUARTER",
"PROPRIETARY AND CONFIDENTIAL 2Q2 2023"
08/08/2023 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position"
07/31/2023 8-K Quarterly results
07/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVE TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT. 11."
07/21/2023 8-K Quarterly results
05/31/2023 8-K Investor presentation
Docs: "Emergent BioSolutions Inc. 2023 Annual Meeting of Stockholders May 25, 2023 Agenda 22023 Virtual Annual Meeting of Stockholders INTRODUCTION 1. Call to"
05/15/2023 8-K Asset disposition
Docs: "Emergent BioSolutions Finalizes Sale of Travel Health Business to Bavarian Nordic GAITHERSBURG, Md., May 15, 2023",
"Unaudited Pro Forma Condensed Consolidated Financial Information"
05/09/2023 8-K Quarterly results
Docs: "LUTIONS REPORTS FINANCIAL RESULTS FOR FIRST QUARTER",
"PROPRIETARY AND CONFIDENTIAL 2Q1 2023"
04/17/2023 8-K Quarterly results
03/29/2023 8-K Quarterly results
03/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "COMPANY CONFIDENTIAL SCHEDULE 1 VESTING CRITERIA FOR"
02/27/2023 8-K Quarterly results
Docs: "LUTIONS REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER",
"PROPRIETARY AND CONFIDENTIAL 2Q4FY 2022"
01/09/2023 8-K Results of Operations and Financial Condition, Cost Associated with Exit or Disposal Activities, Departure of Directors or Ce...
Docs: "of Sharpened Strategic Focus Announces Preliminary 2022 Financial Results GAITHERSBURG, Md., January 9, 2023"
01/05/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "to U.S. Department of Defense GAITHERSBURG, Md., Jan. 5, 2023"
12/06/2022 8-K Quarterly results
11/08/2022 8-K Quarterly results
09/26/2022 8-K Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits &n...
Docs: "Investor Contact Robert Burrows Vice President, Investor Relations"
08/12/2022 8-K Quarterly results
08/01/2022 8-K Quarterly results
Docs: "EMERGENT BIOSOLUTIONS REPORTS FINANCIAL RESULTS FOR SECOND QUARTER",
"PROPRIETARY AND CONFIDENTIAL 22Q 2022"
07/06/2022 8-K Quarterly results
06/07/2022 8-K Quarterly results
06/06/2022 8-K Quarterly results
05/27/2022 8-K Quarterly results
05/18/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
04/28/2022 8-K Quarterly results
Docs: "EMERGENT BIOSOLUTIONS REPORTS FINANCIAL RESULTS FOR FIRST QUARTER",
"PROPRIETARY AND CONFIDENTIAL 21Q 2022"
03/23/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FOR IMMEDIATE RELEASE Investor Contact: Robert G. Burrows Vice President, Investor Relations 240-631-3280"
02/24/2022 8-K Quarterly results
02/22/2022 8-K Quarterly results
01/14/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Investor Contact: Robert G. Burrows Vice President, Investor Relations 240-631-3280"
01/10/2022 8-K Investor presentation
Docs: "Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Results",
"Our Path Forward Robert G. Kramer President"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy